Q99 — HCPCS Level II Codes
- Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml billable
- Q9951 Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml billable
- Q9953 Injection, iron-based magnetic resonance contrast agent, per ml billable
- Q9954 Oral magnetic resonance contrast agent, per 100 ml billable
- Q9955 Injection, perflexane lipid microspheres, per ml billable
- Q9956 Injection, octafluoropropane microspheres, per ml billable
- Q9957 Injection, perflutren lipid microspheres, per ml billable
- Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml billable
- Q9959 High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml billable
- Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml billable
- Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml billable
- Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml billable
- Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml billable
- Q9964 High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml billable
- Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml billable
- Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml billable
- Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml billable
- Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg billable
- Q9982 Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries billable
- Q9983 Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries billable
- Q9991 Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg billable
- Q9992 Injection, buprenorphine extended-release (sublocade), greater than 100 mg billable
- Q9996 Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg billable
- Q9997 Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg billable
- Q9998 Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg billable
- Q9999 Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg billable